<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JCDSA</journal-id><journal-title-group><journal-title>Journal of Cosmetics, Dermatological Sciences and Applications</journal-title></journal-title-group><issn pub-type="epub">2161-4105</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jcdsa.2016.62010</article-id><article-id pub-id-type="publisher-id">JCDSA-66311</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Cholangiosepsis Caused by Neutrophilic Cholangitis in Plaque Psoriasis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>arina</surname><given-names>Bergthaler</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ludwig</surname><given-names>Kramer</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andreas</surname><given-names>Steiner</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Paul</surname><given-names>Sator</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Medicine, KH Hietzing, Vienna, Austria</addr-line></aff><aff id="aff1"><addr-line>Department of Dermatology, KH Hietzing, Vienna, Austria</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>carinabergthaler@hotmail.com(AB)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>04</month><year>2016</year></pub-date><volume>06</volume><issue>02</issue><fpage>81</fpage><lpage>84</lpage><history><date date-type="received"><day>11</day>	<month>January</month>	<year>2016</year></date><date date-type="rev-recd"><day>accepted</day>	<month>7</month>	<year>May</year>	</date><date date-type="accepted"><day>10</day>	<month>May</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Psoriasis is a common inflammatory skin disease with many comorbid conditions. We present a 37-year-old male patient with a history of plaque psoriasis, status febrilis, violent umbilical pain, elevated inflammatory markers and liver parameters. Blood cultures were tested positiv
  e
   for E.
   
  coli
  . 
  Diagnostic findings indicated that mechanical icterus and cholangiosepsis in the context of neutrophilic cholangitis were caused by inflammatory stenosis.
   Neutrophilic cholangitis is often found in combination with skin diseases with intense cutaneous infiltration with polymorphonuclear leucocytes and peripherial blood neutrophilia. Interleukin-8 may play a role in the pathogenesis of neutrophilic cholangitis occurring in patients with psoriasis
   [1]. 
  We showed that complications of psoriasis can also occur at unusual locations. To date no case of neutrophilic cholangitis as an elic
  i
  tor of cholangiosepsis has been reported.
 
</p></abstract><kwd-group><kwd>Plaque Psoriasis</kwd><kwd> Cholangitis</kwd><kwd> Cholangiosepsis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Psoriasis is a common chronic inflammatory skin disease affecting approximately 2% - 3% of persons of European descent [<xref ref-type="bibr" rid="scirp.66311-ref2">2</xref>] . In the past decade many studies focused on comorbid conditions in psoriasis. Recent findings show that psoriasis is a systemic disease. Participation of the joints, cardiovascular system and nervous system, diabetes, hypertension, dyslipidemia and inflammatory bowel disease have been found at a higher prevalence in psoriasis patients compared to the general population (<xref ref-type="table" rid="table1">Table 1</xref>) [<xref ref-type="bibr" rid="scirp.66311-ref3">3</xref>] . Because of the growing range of comorbid conditions, it is important to think of a possible association between psoriasis and other disorders.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Psoriasis-comorbidities as a consequence of systemic inflammation [<xref ref-type="bibr" rid="scirp.66311-ref3">3</xref>] </title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Psoriasis Comorbidities</th><th align="center" valign="middle" >Studies (N)</th><th align="center" valign="middle" >Prevalence (%)</th><th align="center" valign="middle" >95% Cl (%)</th></tr></thead><tr><td align="center" valign="middle" >Anxiety</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >30.2</td><td align="center" valign="middle" >21.7 - 38.8</td></tr><tr><td align="center" valign="middle" >Depression</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >21.7</td><td align="center" valign="middle" >15.1 - 28.3</td></tr><tr><td align="center" valign="middle" >Psoriasis Arthritis</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >24.1</td><td align="center" valign="middle" >19.3 - 29.0</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >8.5</td><td align="center" valign="middle" >7.4 - 9.6</td></tr><tr><td align="center" valign="middle" >Hyperlipidemia</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >7.4</td><td align="center" valign="middle" >6.5 - 8.4</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >21.2</td><td align="center" valign="middle" >19.2 - 23.3</td></tr><tr><td align="center" valign="middle" >Inflammatory Bowel Diseases</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" >0.1 - 1.4</td></tr><tr><td align="center" valign="middle" >Adipositas</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >11.9</td><td align="center" valign="middle" >7.2 - 16.8</td></tr><tr><td align="center" valign="middle" >Cardiovascular Diseases</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >10.2</td><td align="center" valign="middle" >7.7 - 12.8</td></tr></tbody></table></table-wrap><p>We add a case of cholangiosepsis caused by neutrophilic cholangitis.</p></sec><sec id="s2"><title>2. Case Report</title><p>We present a 37-year-old male patient with a medical history of plaque psoriasis. He had one episode of psoriasis in his youth, followed by a long period without a flare. In the past year, he presented with new skin lesions― to date without therapy.</p><p>The patient presented with status febrilis and complained of violent umbilical pain. Laboratory investigations showed: elevated inflammatory markers (CRP 218.9 mg/l, white blood count 12.58 G/l) and raised levels of liver parameters (ASAT 153 U/l, ALAT 195 U/l, y-GT 464 U/l, bilirubin 7.59 mg/dl, LDH 293 U/l, alkaline phosphatase 393 U/l). Blood cultures were tested positive for E. coli.</p><p>Ultrasound scan showed considerable steatosis hepatis and a marginal splenomegaly. The gallbladder had normal size, pencil-thin wall without intraluminal stones and inconspicuous bile ducts.</p><p>Magnetic resonance cholangiopancreatography (MRCP) detected high-grade short distance stenosis of the principal bile duct without prestenotic dilatation or evidence of concretion (  Picture 1 ).</p><p>The performance of an endoscopic retrograde cholangiopancreaticography (ERCP) showed the stenosis restituted by forced administration of a contrast agent. These findings show an inflammatory stricture and no stenosis caused by a tumor (  Picture 2 ).</p><p>The patient’s general condition quickly improved and lab parameters returned to normal levels after he received antibiotics (Ciprofloxacin i.v.). Due to the clinical development, we prescinded from invasive examinations.</p><p>Diagnostic findings indicate that mechanical icterus and cholangiosepsis in the context of neutrophilic cholangitis were caused by inflammatory stenosis and that complications of psoriasis can also occur at unusual locations.</p><p>At the follow-up visit after two months, both cholangitis and skin lesions were healed.</p></sec><sec id="s3"><title>3. Discussion</title><p>The parallel course of liver abnormalities, parameters of cholestasis and psoriasis flares, as well as a negative search for any hepatotoxic drug intake, autoantibodies or viral hepatitis infection, negative history of alcohol misuse and the results of MRCP all reinforced a suspicion of neutrophilic cholangitis [<xref ref-type="bibr" rid="scirp.66311-ref1">1</xref>] .</p><p>The outlined findings in MRCP were similar to the key MRCP features described in patients with generalized pustular psoriasis and neutrophilic cholangitis as well as in patients with neutrophilic cholangitis and psoriasis vulgaris or psoriatic arthritis [<xref ref-type="bibr" rid="scirp.66311-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.66311-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.66311-ref5">5</xref>] .</p><p>MRCP results have been recognized as acceptable criteria, although liver histology remains the gold standard for a diagnosis of neutrophilic cholangitis [<xref ref-type="bibr" rid="scirp.66311-ref1">1</xref>] .</p><p>As described in the literature, we also found a coherence of activity of psoriasis flare and neutrophilic cholangitis [<xref ref-type="bibr" rid="scirp.66311-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.66311-ref5">5</xref>] .</p><disp-formula id="scirp.66311-formula368"><graphic  xlink:href="http://html.scirp.org/file/3-1050342x7.png"  xlink:type="simple"/></disp-formula><p>&#169;KHR</p><p>Picture 1. MRCP―high-grade stricture of the principal bile duct.</p><disp-formula id="scirp.66311-formula369"><graphic  xlink:href="http://html.scirp.org/file/3-1050342x8.png"  xlink:type="simple"/></disp-formula><p>&#169;KHR</p><p>Picture 2. ERCP―restitution of the stenosis by forced administration of contrast agent.</p><p>To date no case of neutrophilic cholangitis as an elicitor of cholangiosepsis has been reported.</p><p>Neutrophilic cholangitis is often found in combination with skin diseases with intense cutaneous infiltration with polymorphonuclear leucocytes and peripheral blood neutrophilia [<xref ref-type="bibr" rid="scirp.66311-ref1">1</xref>] .</p><p>Although the mechanism of neutrophilic infiltration of bile ducts remains speculative, enhanced expression of interleukin-8 has been documented in cholangiocytes from lesion of neutrophilic cholangitis [<xref ref-type="bibr" rid="scirp.66311-ref6">6</xref>] , in keratinocytes from skin lesions of psoriasis vulgaris and general psoriasis pustularis [<xref ref-type="bibr" rid="scirp.66311-ref2">2</xref>] and synovial lesions of psoriasis arthritis [<xref ref-type="bibr" rid="scirp.66311-ref7">7</xref>] .</p><p>In a synopsis of these findings, Interleukin-8 may play a role in the pathogenesis of neutrophilic cholangitis occurring in patients with psoriasis [<xref ref-type="bibr" rid="scirp.66311-ref1">1</xref>] .</p></sec><sec id="s4"><title>4. Conclusions</title><p>The range of comorbid conditions associated with psoriasis has recently grown, and the concept of psoriasis as a systemic inflammatory disorder provides the probable link with neutrophilic cholangitis.</p><p>Because of the high frequency of liver abnormalities in patients with psoriasis, a biliary participation linked with neutrophilic cholangitis should be added to the spectrum of extracutaneous manifestations of psoriasis.</p></sec><sec id="s5"><title>Cite this paper</title><p>Carina Bergthaler,Ludwig Kramer,Andreas Steiner,Paul Sator, (2016) Cholangiosepsis Caused by Neutrophilic Cholangitis in Plaque Psoriasis. Journal of Cosmetics, Dermatological Sciences and Applications,06,81-84. doi: 10.4236/jcdsa.2016.62010</p></sec><sec id="s6"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.66311-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Dieude, P., Sbidian, E., Viguier, M., Zafrani, E., et al. (2013) Neutrophilic Cholangitis in Psoriasis Vulgaris and Psoriatic Arthritis. British Association of Dermatologists, 168, 216-218. http://dx.doi.org/10.1111/j.1365-2133.2012.11157.x</mixed-citation></ref><ref id="scirp.66311-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Marrakchi, S., Guigue, P., Renshaw, B., et al. (2011) Interleukin-36 Receptor Antagonist Deficiency Causes Generalized Pustular Psoriasis. New England Journal of Medicine, 365, 620-628. http://dx.doi.org/10.1056/NEJMoa1013068</mixed-citation></ref><ref id="scirp.66311-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Mrowietz, U., et al. (2010) Comorbidity Prevalence in Psoriasis Patients: A Meta-Analysis. Journal of the American Academy of Dermatology, 6. Poster Presentation at the 68th Annual Meeting of the American Academy of Dermatology, Miami Beach, FL, 5-9 March 2010, 3300.</mixed-citation></ref><ref id="scirp.66311-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Allez, M., Roux, M.E., Bertheau, P., et al. (2000) Recurrent Cholestatic Jaundice Associated with Generalized Pustular Psoriasis: Evidence for a Neutrophilic Cholangitis. Journal of Hepatology, 33, 160-162. http://dx.doi.org/10.1016/S0168-8278(00)80174-9</mixed-citation></ref><ref id="scirp.66311-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Viguier, M., Allez, M., Zagdanski, A.M., et al. (2004) High Frequency of Cholestasis in Generalized Pustular Psoriasis: Evidence for Neutrophilic Involvement of the Biliary Tract. Hepatology, 40, 452-458. http://dx.doi.org/10.1002/hep.20305</mixed-citation></ref><ref id="scirp.66311-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Isse, K., Harada, K. and Nakanuma, Y. (2007) IL-8 Expression by Biliary Epithelial Cells Is Associated with Neutrophilic Infiltraion an Reactive Bile Ductules. Liver International, 27, 672-680. http://dx.doi.org/10.1111/j.1478-3231.2007.01465.x</mixed-citation></ref><ref id="scirp.66311-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kane, D., Roth, J., Frosch, M., et al. (2003) Increased Perivascular Synovial Arthritis. Arthritis &amp; Rheumatology, 48, 1676-1685. http://dx.doi.org/10.1002/art.10988</mixed-citation></ref></ref-list></back></article>